Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 05, 2015 4:27 AM ET

Healthcare Providers and Services

Company Overview of Genelex Corporation

Company Overview

Genelex Corporation operates as a DNA testing laboratory. It provides a program for personalized medication management consisting of DNA sensitivity testing, as well as GeneMedRx software, a software tool that predicts potential drug-drug and drug-gene interaction risk based on cytochrome P450 metabolism and genetic testing for interpreting the test results based on all of the medicines a patient is taking. The company offers services, such as parentage and forensic DNA testing, pharmacogenetic testing, ancestry DNA testing, clinical trial genotyping services, and predicitive genetic testing. Genelex Corporation, through its online store, also offers various at-home or legally admissible DNA...

3000 First Avenue

Suite One

Seattle, WA 98121

United States

Founded in 1987





Key Executives for Genelex Corporation

Co-founder, Chairman of the Board and Chief Executive Officer
Co-founder, Chief Science Officer and Director
Chief Operating Officer
Executive Vice President and Director
Chief Information Officer
Compensation as of Fiscal Year 2015.

Genelex Corporation Key Developments

Genelex Corporation Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 03:25 PM

Genelex Corporation Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 03:25 PM. Venue: Washington State Convention Center, Seattle, Washington, United States.

Genetic Technologies Limited Announces Settlement and Release Agreement with Genelex Corporation

Genetic Technologies Limited reported it has now executed a settlement and release agreement with Genelex Corporation. In late 2012, GTG reported that it had filed suit against Genelex Corporation in the United States District Court for the Western District of Washington at Seattle, under its Assertion program in USA. Given the Parties have now reached a final settlement, such legal action against Genelex Corporation is now being dismissed. This settlement was achieved as a result of GTG's continuing patent monetization efforts in the US and other jurisdictions.

Similar Private Companies By Industry

Company Name Region
CareMore Health Group, Inc. United States
Rochester Dialysis Center, LLC United States
Prestige Brands Inc. United States
Encore Home Health Care, Inc. United States
Rosecrance Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genelex Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at